MarketScreener Strategies StemRIM

Stocks

4599

JP3399690001

Pharmaceuticals

Delayed Japan Exchange Other stock markets 02:24:38 2026-08-07 EDT			5-day change	1st Jan Change
306.00 ^JPY	+0.99%		+2.68%	+16.35%

07-22	Stemrim Announces Patent Registration in Mexico for Redasemtide as Therapeutic Agent for Cartilage Disorders	CI
07-08	StemRIM Inc. Announces Patent Registration For Stem Cell Gene Therapy Technology SR-GT1 Aimed At Curative Treatment Of Dystrophic Epidermolysis Bullosa In South Korea	CI

MarketScreener Strategies

No results match your criteria

All News Broker Recommendations Highlights Insiders Transcripts Press Releases Official Publications Other languages MarketScreener Editorial Features MarketScreener Strategies

Filters

Rankings

Rankings

Currency / Forex

Commodities

Cryptocurrencies

Interest Rates

Stock Market
Stocks
4599 Stock
News StemRIM
MarketScreener Strategies

The best tools reserved for subscribers to boost the performance of your investments!

×